Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
No price history available for this symbol yet.
No one on the platform currently holds CRDL.TO.
No tracked institution reports a position in CRDL.TO as of their last filing.
No one on the platform has traded CRDL.TO yet.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $2M | — | $-0.47 | $-0.65–$-0.33 | — | 4 |
| 2027 | $4M | +176.1% | $-0.23 | $-0.35–$-0.15 | — | 3 |
| 2028 | $48M | +1066.7% | $0.05 | $-0.27–$0.51 | — | 3 |
| 2029 | $98M | +102.1% | $0.32 | $0.32–$0.32 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 5 of the last 8 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-13 | $-0.09 | $-0.05 | +48.3% |
| 2026-05-14 | $-0.09 | $-0.10 | -11.1% |
| 2026-04-01 | $-0.11 | $-0.07 | +38.8% |
| 2025-11-13 | $-0.11 | $-0.12 | -6.9% |
| 2025-08-14 | $-0.13 | $-0.10 | +22.2% |
| 2025-05-12 | $-0.14 | $-0.10 | +28.6% |
| 2025-03-31 | $-0.13 | $-0.10 | +21.1% |
| 2024-11-14 | $-0.12 |
| $-0.18 |
| -50.0% |
| +3.17% |
| $130M |
| — |
| LOVE.VCannara Biotech Inc. | $1.89 | +6.18% | $181M | — |
| MSCL.TOSatellos Bioscience Inc. | $13.85 | +0.29% | $289M | — |
Source: Financial Modeling Prep · peers by sector/industry